Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Cox

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Frontiers in Molecular Biosciences|October 2, 2020
Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the MindTimothy M Cox
Current Opinion in Investigational Drugs (London, England : 2000)|September 28, 2010
Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseasesTimothy M Cox
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
Innovative treatments for lysosomal diseasesTimothy M Cox
American Journal of Hematology|February 13, 2013
Competing for the treasure in exceptionsTimothy M Cox
JIMD Reports|February 23, 2013
Alkaptonuria: leading to the treasure in exceptionsTimothy M Cox
Biologics : Targets & Therapy|January 7, 2011
Gaucher disease: clinical profile and therapeutic developmentsTimothy M Cox
Nature Reviews. Genetics|June 4, 2002
The genetic consequences of our sweet toothTimothy M Cox
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 14, 2003
Future perspectives for glycolipid research in medicineTimothy M Cox
Blood Cells, Molecules & Diseases|December 22, 2009
Recommendations for treating patients with Gaucher disease with emerging enzyme productsTimothy M Cox
Journal of Inherited Metabolic Disease|September 23, 2011
Alkaptonuria: treasure your exceptionsTimothy M Cox
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Frontiers in Molecular Biosciences|October 2, 2020
Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the MindTimothy M Cox
Current Opinion in Investigational Drugs (London, England : 2000)|September 28, 2010
Eliglustat tartrate, an orally active glucocerebroside synthase inhibitor for the potential treatment of Gaucher disease and other lysosomal storage diseasesTimothy M Cox
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
Innovative treatments for lysosomal diseasesTimothy M Cox
American Journal of Hematology|February 13, 2013
Competing for the treasure in exceptionsTimothy M Cox
JIMD Reports|February 23, 2013
Alkaptonuria: leading to the treasure in exceptionsTimothy M Cox
Biologics : Targets & Therapy|January 7, 2011
Gaucher disease: clinical profile and therapeutic developmentsTimothy M Cox
Nature Reviews. Genetics|June 4, 2002
The genetic consequences of our sweet toothTimothy M Cox
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|June 14, 2003
Future perspectives for glycolipid research in medicineTimothy M Cox
Blood Cells, Molecules & Diseases|December 22, 2009
Recommendations for treating patients with Gaucher disease with emerging enzyme productsTimothy M Cox
Journal of Inherited Metabolic Disease|September 23, 2011
Alkaptonuria: treasure your exceptionsTimothy M Cox
Pageof 12